First Trust Direct Indexing’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,901
Closed -$402K 309
2024
Q3
$402K Buy
+5,901
New +$333K 0.02% 619
2021
Q3
Sell
-2,020
Closed -$251K 661
2021
Q2
$251K Buy
+2,020
New +$241K 0.04% 507
2021
Q1
Sell
-1,053
Closed -$140K 579
2020
Q4
$140K Buy
+1,053
New +$127K 0.04% 416

Other funds holding EXAS

First Trust Direct Indexing's EXAS Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 5,901 shares — an estimated $402K sold.

First Trust Direct Indexing first reported a position in EXAS in Q4 2020 and held it in 3 quarters. The position peaked at $402K in Q3 2024. 592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 5,901 Exact Sciences shares in Q4 2024, an estimated $402K.
  • First Trust Direct Indexing first reported a position in Exact Sciences in Q4 2020 and held it in 3 quarters.
  • First Trust Direct Indexing's Exact Sciences position peaked at $402K in Q3 2024.
  • 592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.